Heliad AG (A7A) Fair Value & Analysis
Financial Services · DE · Market cap €121M
Fair value as of: May 31, 2026
Analysis
Heliad AG (A7A) currently trades at €13.45, while our model-based Fair Value estimate is €26.90 — implying the stock looks roughly 100.0% undervalued today. We read business quality at 95/100 (high quality), in the Financial Services sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
About the company
Heliad AG is a venture capital firm specializing in multistage, pre-seed, startups, series A-C until IPO, early venture and growth capital investments. The firm also invests in direct and indirect funds. It prefers to invest in blockchain, online financial services and financial technology and software sectors. The firm also invests in AI agents and robotics, next-gen finance, AI health, energy transition, and seamless mobility sectors. It seeks to invest globally with a primary focus on western Europe and DACH region. For funds of fund investments, the firm seeks to invest in funds specializing in fintech companies especially in the US and Asia. It also considers co-investment opportunities. It seeks to take minority and majority stakes in venture capital investments. Heliad AG makes balance sheet investments, was founded in 2003 and is based in Frankfurt am Main, Germany.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Heliad AG (A7A) undervalued?
What is the fair value of A7A?
What is the quality score of A7A?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.